Ethyol Alternatives Compared
Ethyol (amifostine) | Pilocarpine | Salagen (pilocarpine) |
|
---|
Ethyol (amifostine) | Pilocarpine | Salagen (pilocarpine) |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Chemotherapy Toxicity, Xerostomia. Ethyol may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Xerostomia. Pilocarpine may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Xerostomia. Salagen may also be used for purposes not listed in this medication guide. |
Related suggestions |
|||||||||||||||
More about Ethyol (amifostine) | More about Pilocarpine | More about Salagen (pilocarpine) | ||||||||||||||||
Ratings & Reviews | ||||||||||||||||||
Be the first to share your experience with this drug. |
Pilocarpine has an average rating of 6.1 out of 10 from a total of 16 ratings on Drugs.com. 50% of reviewers reported a positive effect, while 31% reported a negative effect. |
Salagen has an average rating of 7.6 out of 10 from a total of 5 ratings on Drugs.com. 80% of reviewers reported a positive effect, while 20% reported a negative effect. |
||||||||||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||
View all Ethyol side effects |
View all Pilocarpine side effects |
View all Salagen side effects |
||||||||||||||||
Drug Class | ||||||||||||||||||
Generic Availability | ||||||||||||||||||
N/A |
Lower cost generic |
|||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Pilocarpine prices |
View all Salagen prices |
||||||||||||||||
Dosage Forms | ||||||||||||||||||
|
|
|
||||||||||||||||
Brand Names | ||||||||||||||||||
N/A |
Salagen |
N/A |
||||||||||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||
6 hours |
N/A |
N/A |
||||||||||||||||
CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | ||||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | ||||||||||||||||||
A total of 123 drugs are known to interact with Ethyol:
|
A total of 86 drugs are known to interact with Pilocarpine:
|
A total of 86 drugs are known to interact with Salagen:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
Disease Interactions | ||||||||||||||||||
First Approval Date | ||||||||||||||||||
December 08, 1995 |
March 22, 1994 |
March 22, 1994 |
||||||||||||||||
WADA Class View classifications | ||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||
More Information | ||||||||||||||||||
Patient Resources | ||||||||||||||||||
Professional Resources | ||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.